Cargando…
Comparative Effectiveness of Regimens for Drug-Susceptible Tuberculous Meningitis in Children and Adolescents: A Systematic Review and Aggregate-Level Data Meta-Analysis
BACKGROUND: Before August 2021, the only regimen recommended by the World Health Organization (WHO) to treat pediatric drug-susceptible tuberculous meningitis was a 12-month regimen consisting of isoniazid, rifampicin, ethambutol, and pyrazinamide (2HRZE/10HR). The comparative effectiveness of short...
Autores principales: | Sulis, Giorgia, Tavaziva, Gamuchirai, Gore, Genevieve, Benedetti, Andrea, Solomons, Regan, van Toorn, Ronald, Thee, Stephanie, Day, Jeremy, Verkuijl, Sabine, Brands, Annemieke, Viney, Kerri, Masini, Tiziana, Ahmad Khan, Faiz, Chiang, Silvia S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167638/ https://www.ncbi.nlm.nih.gov/pubmed/35673608 http://dx.doi.org/10.1093/ofid/ofac108 |
Ejemplares similares
-
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
por: Wasmann, Roeland E., et al.
Publicado: (2023) -
The Impact of Hyponatremia on the Severity of Childhood Tuberculous Meningitis
por: Salih, Rashid, et al.
Publicado: (2022) -
Child with tuberculous meningitis and COVID-19 coinfection complicated by extensive cerebral sinus venous thrombosis
por: Essajee, Farida, et al.
Publicado: (2020) -
International Survey Reveals Opportunities to Improve Tuberculous Meningitis Management and the Need for Standardized Guidelines
por: Tucker, Elizabeth W, et al.
Publicado: (2020) -
Risk factors of poor developmental outcome in children with tuberculous meningitis
por: Saal, Caro-Lee, et al.
Publicado: (2022)